[Federal Register Volume 69, Number 24 (Thursday, February 5, 2004)]
[Notices]
[Page 5557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-2375]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Biodefense & Emerging Infectious 
Diseases: Choosing Drug Doses for BioD Pathogens.
    Date: February 23, 2004.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700-B Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Robert C. Goldman, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, DHHS, Room 3124, 6700-B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7816, (301) 496-8424, <a href="/cdn-cgi/l/email-protection#5b293c6a6e622c1b353233753c342d"><span class="__cf_email__" data-cfemail="34465305010d43745a5d5c1a535b42">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Unsolicited P01 Application on B 
Cell Biology.
    Date: February 25, 2004.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health/NIAID, 6700 B, Rockledge 
Drive, 3131, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Katherine L. White, PhD, Scientific Review 
Administrator, AIDS Preclinical Research Review Branch, Scientific 
Review Program, NIH/NIAID, 6700 B Rockledge Drive, Room 3131, 
Bethesda, MD 20892, (301) 435-1615, <a href="/cdn-cgi/l/email-protection#9ef5e9afa9aafcdef0f7f6b0f9f1e8"><span class="__cf_email__" data-cfemail="147f6325232076547a7d7c3a737b62">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Review of Four Unsolicited R13 
Applications.
    Date: March 8, 2004.
    Time: 10:30 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Quirijn Vos, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-496-2500, 
<a href="/cdn-cgi/l/email-protection#c4b5b2abb784aaada5ada0eaaaadaceaa3abb2"><span class="__cf_email__" data-cfemail="166760796556787f777f7238787f7e38717960">[email protected]</span></a>.


(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 28, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-2375 Filed 2-4-04; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>